The case for CMR

doi:10.1007/s12350-015-0147-y

PMID: 26153261DOI: 10.1007/s12350-015-0147-yJul 15, 2015Paper

The case for CMR

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology

Peter W Shaw, Christopher M Kramer

Get PDF

Abstract

No abstract listed.

References

Quantification in cardiac MRI

Nov 5, 1999·Journal of Magnetic Resonance Imaging : JMRI·R J van der Geest, J H Reiber

Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging

Sep 12, 2001·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·C H LorenzT P Graham

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

Mar 27, 2002·European Heart Journal·L J AndersonD J Pennell

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

Jun 25, 2003·Circulation·J A McCrohonD J Pennell

Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance

Mar 1, 2005·Journal of the American College of Cardiology·Carlos J SorianoJosé A De Velasco

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

Apr 16, 2005·European Heart Journal·Heiko MahrholdtRaymond J Kim

Cardiovascular magnetic resonance: structure, function, perfusion, and viability

Jun 10, 2005·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·David C Isbell, Christopher M Kramer

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy

Nov 23, 2006·Journal of the American College of Cardiology·Ravi G AssomullDudley J Pennell

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Jun 21, 2008·Journal of the American College of Cardiology·Katherine C WuJoão A C Lima

Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies

Aug 12, 2008·Topics in Magnetic Resonance Imaging : TMRI·Monda L ShehataDavid A Bluemke

Cardiovascular MRI for the assessment of heart failure: focus on clinical management and prognosis

Jan 29, 2011·Journal of Magnetic Resonance Imaging : JMRI·Stefano MuzzarelliCharles B Higgins

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

Feb 19, 2011·Journal of the American College of Cardiology·Nathan MewtonJoão A C Lima

Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping.

Nov 1, 2011·Circulation. Cardiovascular Imaging·Paaladinesh ThavendiranathanSubha V Raman

Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping

Mar 2, 2013·Journal of Magnetic Resonance Imaging : JMRI·Jeremy BrooksMichael Salerno

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

Mar 19, 2013·JACC. Cardiovascular Imaging·Theodoros D KaramitsosJames C Moon

Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Mar 19, 2013·JACC. Cardiovascular Imaging·Valentina O PuntmannEike Nagel

Advances in parametric mapping with CMR imaging

Jul 13, 2013·JACC. Cardiovascular Imaging·Michael Salerno, Christopher M Kramer

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.

Sep 10, 2013·JACC. Cardiovascular Imaging·Vanessa M FerreiraStefan Neubauer

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Oct 16, 2013·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·James C MoonUNKNOWN Cardiovascular Magnetic Resonance Working Group of the European Society of Cardiology

Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis

Dec 24, 2013·Circulation. Cardiovascular Imaging·Sujith KuruvillaMichael Salerno

❮ Previous

Next ❯

Citations

Imaging the patient with a new diagnosis of heart failure in the contemporary era

Jul 15, 2015·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·James E Udelson

Non-invasive assessment of low- and intermediate-risk patients with chest pain

Oct 9, 2016·Trends in Cardiovascular Medicine·Pelbreton C BalfourChristopher M Kramer

Cardiac MRI for the evaluation of oncologic cardiotoxicity

May 8, 2018·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Adrián I Löffler, Michael Salerno

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

The case for CMR

Abstract

References

Quantification in cardiac MRI

Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging

Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload

Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance

Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

Cardiovascular magnetic resonance: structure, function, perfusion, and viability

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies

Cardiovascular MRI for the assessment of heart failure: focus on clinical management and prognosis

Assessment of myocardial fibrosis with cardiovascular magnetic resonance

Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping.

Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping

Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis.

Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Advances in parametric mapping with CMR imaging

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.

Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.

Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis

Citations

Imaging the patient with a new diagnosis of heart failure in the contemporary era

Non-invasive assessment of low- and intermediate-risk patients with chest pain

Cardiac MRI for the evaluation of oncologic cardiotoxicity

Related Concepts

Related Feeds

Cardiomyopathy

Related Papers

Ventricular volume and mass by CMR

CMR and MSCT: what is the future?

CMR for the diagnosis of right heart disease

3D echocardiography: is CMR better?

RV volume measurements by CMR